Page last updated: 2024-09-04

alpinetin and Liver Neoplasms

alpinetin has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, J; Gao, Z; Tan, G; Tang, B; Wang, J; Wang, L; Wang, Z	1

Other Studies

1 other study(ies) available for alpinetin and Liver Neoplasms

Article	Year
Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium. Oncology reports, 2012, Volume: 27, Issue:4 Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Activators; Flavanones; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Kinase 7; Phosphorylation; Protein Kinase Inhibitors; Rats; Resting Phase, Cell Cycle; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Time Factors; Transfection	2012

Article

Year

Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium.

Oncology reports, 2012, Volume: 27, Issue:4

Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Activators; Flavanones; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Kinase 7; Phosphorylation; Protein Kinase Inhibitors; Rats; Resting Phase, Cell Cycle; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Time Factors; Transfection

2012